In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers
who are quitting smoking
PITTSBURGH, May 23 /PRNewswire/ -- With the Federal Aviation
Administration's (FAA) recent announcement to remove a prescription
anti-smoking pill from their approved list of safe medications for pilots,
GSK Consumer Healthcare, an industry leader in smoking cessation, is
offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all
licensed commercial and private pilots who are interested in quitting
smoking today, through June 30. It is important for pilots to understand
that NRT has been the recommended aid for pilots to quit smoking since
1994, and that the FAA news in no way includes GSK's products, which are
deemed safe and effective medicines to relieve nicotine withdrawal symptoms
that arise during a quit attempt.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gsk/33419/
Recent clinical research has demonstrated that the Commit 4 mg lozenge reverses the negative impact that nicotine withdrawal has on the ability to concentrate, attention deficit, short-term memory and selective attention during a quit attempt(1) -- all these issues were at the core of the FAA's ruling.
"It's important that pilots interested in quitting have access to safe, evidence-based treatments," said Bill Slivka, vice president, Smoking Control, GlaxoSmithKline Consumer Healthcare. "Over the past ten years, our NRT products, including the Commit lozenge, have helped more than 6.5 million smokers around the world quit. This free offer to pilots and air traffic controllers further demonstrates our mission to help more smokers achieve their goal of safely becoming smoke-free."
The Commit lozenge give-away program is open to all U.S. residents,
'/>"/>
| SOURCE GlaxoSmithKline Consumer Healthcare Copyright©2008 PR Newswire. All rights reserved |